N

Minerva Neurosciences
D

NERV

1.73000
USD
-0.02
(-1.14%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
9
حجم السوق
12,098,592
أصول ذات صلة
A
ANVS
0.03500
(2.22%)
1.61500 USD
C
CRVS
0.12000
(3.43%)
3.62000 USD
C
CYCC
0.00290
(1.16%)
0.25200 USD
M
MGTX
0.00000
(0.00%)
7.27000 USD
NTRA
NTRA
5.240
(3.46%)
156.660 USD
X
XNCR
0.420
(3.87%)
11.270 USD
المزيد
الأخبار المقالات

العنوان: Minerva Neurosciences

القطاع: Healthcare
الصناعة: Biotechnology
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.